Current status and future perspectives of cooperative study groups for lung cancer in Japan-Reference-Cited by-同舟云学术

Current status and future perspectives of cooperative study groups for lung cancer in Japan

Published:2014-11 Issue:6 Volume:52 Page:339-347
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Kawano Yuko,Okamoto Isamu,Fukuda Haruhiko,Ohe Yuichiro,Nakamura Shinichiro,Nakagawa Kazuhiko,Hotta Katsuyuki,Kiura Katsuyuki,Takiguchi Yuichi,Saka Hideo,Okamoto Hiroaki,Takayama Koichi,Semba Hiroshi,Kobayashi Kunihiko,Kenmotsu Hirotsugu,Tsuboi Masahiro,Yamamoto Nobuyuki,Nukiwa Toshihiro,Nakanishi Yoichi

Funder

National Cancer Center Research and Development Fund

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference21 articles.

1. Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study;Okamoto;J Clin Oncol,2010

2. Phase III study comparing amrubicin plus cisplatin with irinotecan plus cisplatin in the treatment of extensive-disease small-cell lung cancer: JCOG 0509;Satouchi;J Clin Oncol,2014

3. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer;Noda;N Engl J Med,2002

4. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702;Okamoto;Br J Cancer,2007

5. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent trends in the treatment of unresectable stage III non-small-cell lung cancer;Respiratory Investigation;2019-07

2. Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non–Small-Cell Lung Cancer: The JIPANG Study Protocol;Clinical Lung Cancer;2018-01

3. Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2017-01

4. SC15.04 The Japanese Perspective;Journal of Thoracic Oncology;2017-01